Literature DB >> 31662500

Amelioration of Mucositis in Proton Therapy of Fanconi Anemia Fanca-/- Mice by JP4-039.

Thomas J Quinn1, Xuanfeng Ding1, Xiaoqiang Li1, George D Wilson1, Katie Buelow1, Aranee Sivananthan2, Stephanie Thermozier2, Andrew Henderson2, Michael W Epperly2, Darcy Franicola2, Peter Wipf3, Joel S Greenberger2, Craig W Stevens1, Peyman Kabolizadeh4.   

Abstract

BACKGROUND/AIM: We tested JP4-039, a GS-nitroxide radiation damage mitigator in proton therapy of Fanconi anemia (FA) mice.
MATERIALS AND METHODS: Fanca-/- and Fanca+/+ bone marrow stromal cells were pre-treated with JP4-039 and irradiated with either protons or photons (0-10 GyRBE) followed by clonogenic survival and β-Galactosidase senescence analysis. Fanca-/- and Fanca+/+ mice were pretreated with JP4-039 for 10 min prior to oropharyngeal irradiation with either protons or photons (0 or 30 GyRBE) followed by sacrifice and measurement of oral cavity ulceration, distant hematopoietic suppression, and real-time polymerase chain reaction analysis.
RESULTS: JP4-039 reduced oral cavity ulceration in Fanca-/- mice, transcripts Nfkb, Ap1, Sp1, and Nrf2, and proton therapy induced distant marrow suppression.
CONCLUSION: JP4-039 protected Fanca-/- and Fanca+/+ cells and mouse oral cavity from both proton and photon radiation. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Fanconi anemia; mucositis; proton; radiation protector; toxicity

Mesh:

Substances:

Year:  2019        PMID: 31662500      PMCID: PMC6899135          DOI: 10.21873/invivo.11666

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  26 in total

Review 1.  Inherited bone marrow failure syndromes.

Authors:  Janine Collins; Inderjeet Dokal
Journal:  Hematology       Date:  2015-08       Impact factor: 2.269

2.  Esophageal radioprotection by swallowed JP4-039/F15 in thoracic-irradiated mice with transgenic lung tumors.

Authors:  Michael W Epperly; Julie P Goff; Darcy Franicola; Hong Wang; Peter Wipf; Song Li; Joel S Greenberger
Journal:  In Vivo       Date:  2014 Jul-Aug       Impact factor: 2.155

Review 3.  Relative biological effectiveness (RBE) values for proton beam therapy. Variations as a function of biological endpoint, dose, and linear energy transfer.

Authors:  Harald Paganetti
Journal:  Phys Med Biol       Date:  2014-10-31       Impact factor: 3.609

4.  Radiobiologic effects of GS-nitroxide (JP4-039) on the hematopoietic syndrome.

Authors:  Julie P Goff; Michael W Epperly; Tracy Dixon; Hong Wang; Darcy Franicola; Donna Shields; Peter Wipf; Song Li; Xiang Gao; Joel S Greenberger
Journal:  In Vivo       Date:  2011 May-Jun       Impact factor: 2.155

5.  Continuous One Year Oral Administration of the Radiation Mitigator, MMS350, after Total-Body Irradiation, Restores Bone Marrow Stromal Cell Proliferative Capacity and Reduces Senescence in Fanconi Anemia (Fanca-/-) Mice.

Authors:  Aranee Sivananthan; Donna Shields; Renee Fisher; Wen Hou; Xichen Zhang; Darcy Franicola; Michael W Epperly; Peter Wipf; Joel S Greenberger
Journal:  Radiat Res       Date:  2018-11-30       Impact factor: 2.841

6.  Intraoral Mitochondrial-Targeted GS-Nitroxide, JP4-039, Radioprotects Normal Tissue in Tumor-Bearing Radiosensitive Fancd2(-/-) (C57BL/6) Mice.

Authors:  Ashwin Shinde; Hebist Berhane; Byung Han Rhieu; Ronny Kalash; Karen Xu; Julie Goff; Michael W Epperly; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Kalindi Parmar; Eva Guinan; Valerian Kagan; Vladimir Tyurin; Robert L Ferris; Xiaolan Zhang; Song Li; Joel S Greenberger
Journal:  Radiat Res       Date:  2016-01-20       Impact factor: 2.841

7.  Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis.

Authors:  Michael W Epperly; Julie P Goff; Song Li; Xiang Gao; Peter Wipf; Tracy Dixon; Hong Wang; Darcy Franicola; Hongmei Shen; Jean-Claude M Rwigema; Valerian Kagan; Mark Bernard; Joel S Greenberger
Journal:  In Vivo       Date:  2010 Nov-Dec       Impact factor: 2.155

8.  Effects of MnSOD-plasmid liposome gene therapy on antioxidant levels in irradiated murine oral cavity orthotopic tumors.

Authors:  Michael W Epperly; Rodney Wegner; Anthony J Kanai; Valerian Kagan; Emily E Greenberger; Suhua Nie; Joel S Greenberger
Journal:  Radiat Res       Date:  2007-03       Impact factor: 2.841

9.  Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.

Authors:  Hebist Berhane; Ashwin Shinde; Ronny Kalash; Karen Xu; Michael W Epperly; Julie Goff; Darcy Franicola; Xichen Zhang; Tracy Dixon; Donna Shields; Hong Wang; Peter Wipf; Song Li; Xiang Gao; Joel S Greenberger
Journal:  Radiat Res       Date:  2014-06-16       Impact factor: 2.841

10.  A mitochondria-targeted nitroxide/hemigramicidin S conjugate protects mouse embryonic cells against gamma irradiation.

Authors:  Jianfei Jiang; Natalia A Belikova; Adam T Hoye; Qing Zhao; Michael W Epperly; Joel S Greenberger; Peter Wipf; Valerian E Kagan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-03-01       Impact factor: 7.038

View more
  1 in total

1.  Fanconi Anemia Mouse Genotype-specific Mitigation of Total Body Irradiation by GS-Nitroxide JP4-039.

Authors:  Michael W Epperly; Renee Fisher; Xichen Zhang; Wen Hou; Donna Shields; Peter Wipf; Hong Wang; Stephanie Thermozier; Joel S Greenberger
Journal:  In Vivo       Date:  2020 Jan-Feb       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.